These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage? Gouzoulis-Mayfrank E; Daumann J Addiction; 2006 Mar; 101(3):348-61. PubMed ID: 16499508 [TBL] [Abstract][Full Text] [Related]
4. [Acute and long-term effects of ecstasy]. Salzmann J; Marie-Claire C; Noble F Presse Med; 2004 Oct; 33(18 Suppl):24-32. PubMed ID: 15617173 [TBL] [Abstract][Full Text] [Related]
5. The agony of ecstasy: MDMA (3,4-methylenedioxymethamphetamine) and the kidney. Campbell GA; Rosner MH Clin J Am Soc Nephrol; 2008 Nov; 3(6):1852-60. PubMed ID: 18684895 [TBL] [Abstract][Full Text] [Related]
6. The "ecstasy" hangover: hyponatremia due to 3,4-methylenedioxymethamphetamine. Traub SJ; Hoffman RS; Nelson LS J Urban Health; 2002 Dec; 79(4):549-55. PubMed ID: 12468674 [TBL] [Abstract][Full Text] [Related]
7. The health effects of ecstasy: a literature review. Gowing LR; Henry-Edwards SM; Irvine RJ; Ali RL Drug Alcohol Rev; 2002 Mar; 21(1):53-63. PubMed ID: 12189005 [TBL] [Abstract][Full Text] [Related]
8. Hyponatraemia and seizures after ecstasy use. Holmes SB; Banerjee AK; Alexander WD Postgrad Med J; 1999 Jan; 75(879):32-3. PubMed ID: 10396584 [TBL] [Abstract][Full Text] [Related]
9. High incidence of mild hyponatraemia in females using ecstasy at a rave party. van Dijken GD; Blom RE; Hené RJ; Boer WH; NIGRAM Consortium Nephrol Dial Transplant; 2013 Sep; 28(9):2277-83. PubMed ID: 23476039 [TBL] [Abstract][Full Text] [Related]
10. Ecstasy: dangers and controversies. Pham JV; Puzantian T Pharmacotherapy; 2001 Dec; 21(12):1561-5. PubMed ID: 11765306 [TBL] [Abstract][Full Text] [Related]
11. [Psychiatric and cognitive long-term effects of ecstasy]. Høiseth G; Løvåsdal Ø; Titze TK; Bramness JG; Bachs L Tidsskr Nor Laegeforen; 2006 Feb; 126(5):596-8. PubMed ID: 16505868 [TBL] [Abstract][Full Text] [Related]
12. Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; 'ecstasy'). McCann UD; Slate SO; Ricaurte GA Drug Saf; 1996 Aug; 15(2):107-15. PubMed ID: 8884162 [TBL] [Abstract][Full Text] [Related]
13. Hyponatraemia, seizures and stupor associated with ecstasy ingestion in a female. Magee C; Staunton H; Tormey W; Walshe JJ Ir Med J; 1998; 91(5):178. PubMed ID: 9973755 [No Abstract] [Full Text] [Related]
14. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love"). McNamara R; Kerans A; O'Neill B; Harkin A Neuropharmacology; 2006 Jan; 50(1):69-80. PubMed ID: 16188283 [TBL] [Abstract][Full Text] [Related]
16. Death by "ecstasy": the serotonin syndrome? Mueller PD; Korey WS Ann Emerg Med; 1998 Sep; 32(3 Pt 1):377-80. PubMed ID: 9737504 [TBL] [Abstract][Full Text] [Related]
17. Impaired cognitive performance in drug free users of recreational ecstasy (MDMA). Gouzoulis-Mayfrank E; Daumann J; Tuchtenhagen F; Pelz S; Becker S; Kunert HJ; Fimm B; Sass H J Neurol Neurosurg Psychiatry; 2000 Jun; 68(6):719-25. PubMed ID: 10811694 [TBL] [Abstract][Full Text] [Related]
18. Ecstasy intoxication: an overlap between serotonin syndrome and neuroleptic malignant syndrome. Demirkiran M; Jankovic J; Dean JM Clin Neuropharmacol; 1996 Apr; 19(2):157-64. PubMed ID: 8777769 [TBL] [Abstract][Full Text] [Related]
19. Ecstasy intoxication: the toxicological basis for treatment. Ferigolo M; Machado AG; Oliveira NB; Barros HM Rev Hosp Clin Fac Med Sao Paulo; 2003; 58(6):332-41. PubMed ID: 14762493 [TBL] [Abstract][Full Text] [Related]